- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/19 - InterféronsLymphokinesCytokines
Détention brevets de la classe C12N 15/19
Brevets de cette classe: 197
Historique des publications depuis 10 ans
7
|
2
|
10
|
2
|
10
|
11
|
12
|
7
|
5
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 19961 |
5 |
National University Corporation Kanazawa University | 244 |
5 |
Regeneron Pharmaceuticals, Inc. | 4288 |
5 |
Genentech, Inc. | 3976 |
4 |
Chugai Seiyaku Kabushiki Kaisha | 1362 |
4 |
Institute for Research in Biomedicine (IRB) | 40 |
4 |
Yale University | 2394 |
4 |
Actym Therapeutics, Inc. | 30 |
4 |
Nissan Chemical Corporation | 2033 |
4 |
Apollo Life Sciences Limited | 11 |
3 |
Knc Laboratories Co., Ltd. | 37 |
3 |
Kyoto University | 2801 |
3 |
OncoMed Pharmaceuticals, Inc. | 77 |
3 |
Sunshine Lake Pharma Co., Ltd. | 597 |
3 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3166 |
3 |
Warsaw Orthopedic, Inc. | 3017 |
2 |
The Trustees of Columbia University in the City of New York | 3577 |
2 |
Kagoshima University | 310 |
2 |
National University Corporation Kobe University | 525 |
2 |
NGM Biopharmaceuticals, Inc. | 178 |
2 |
Autres propriétaires | 130 |